Influence of the watch and wait strategy on clinical outcomes of patients with follicular lymphoma in the rituximab era
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-0584
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Influence of the watch and wait strategy on clinical outcomes of patients with follicular lymphoma in the rituximab era ; volume:95 ; number:12 ; day:26 ; month:9 ; year:2016 ; pages:2017-2022 ; date:12.2016
Annals of hematology ; 95, Heft 12 (26.9.2016), 2017-2022, 12.2016
- Creator
-
Yuda, Sayako
- Contributor
-
Maruyama, Dai
Maeshima, Akiko Miyagi
Makita, Shinichi
Kitahara, Hideaki
Miyamoto, Ken-ichi
Fukuhara, Suguru
Munakata, Wataru
Suzuki, Tatsuya
Kobayashi, Yukio
Tajima, Kinuko
Taniguchi, Hirokazu
Tobinai, Kensei
SpringerLink (Online service)
- DOI
-
10.1007/s00277-016-2800-1
- URN
-
urn:nbn:de:1111-2016112710670
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:49 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Yuda, Sayako
- Maruyama, Dai
- Maeshima, Akiko Miyagi
- Makita, Shinichi
- Kitahara, Hideaki
- Miyamoto, Ken-ichi
- Fukuhara, Suguru
- Munakata, Wataru
- Suzuki, Tatsuya
- Kobayashi, Yukio
- Tajima, Kinuko
- Taniguchi, Hirokazu
- Tobinai, Kensei
- SpringerLink (Online service)
Other Objects (12)
Long-term outcomes of patients with primary intestinal follicular lymphoma managed with watch-and-wait strategy
Has the time to come leave the “watch-and-wait” strategy in newly diagnosed asymptomatic follicular lymphoma patients?
Follicular lymphoma
Watch and Wait, Worth It?
Rituximab response in follicular lymphoma: contributions from KIR 2DS1 and HLA-C
Systemic and Intra-Nodal Activation of NK Cells After Rituximab Monotherapy for Follicular Lymphoma
A rare face of follicular lymphoma: reverse variant of follicular lymphoma
Atypical burkitt's lymphoma transforming from follicular lymphoma
Follicular lymphoma of the duodenum
Follicular lymphoma of the duodenum
Follicular lymphoma and marginal zone lymphoma: how many diseases?
Constitutive AKT activation in follicular lymphoma
Long-term outcomes of patients with primary intestinal follicular lymphoma managed with watch-and-wait strategy
Has the time to come leave the “watch-and-wait” strategy in newly diagnosed asymptomatic follicular lymphoma patients?
Follicular lymphoma
Watch and Wait, Worth It?
Rituximab response in follicular lymphoma: contributions from KIR 2DS1 and HLA-C
Systemic and Intra-Nodal Activation of NK Cells After Rituximab Monotherapy for Follicular Lymphoma
A rare face of follicular lymphoma: reverse variant of follicular lymphoma
Atypical burkitt's lymphoma transforming from follicular lymphoma
Follicular lymphoma of the duodenum
Follicular lymphoma of the duodenum
Follicular lymphoma and marginal zone lymphoma: how many diseases?
Constitutive AKT activation in follicular lymphoma
Long-term outcomes of patients with primary intestinal follicular lymphoma managed with watch-and-wait strategy
Has the time to come leave the “watch-and-wait” strategy in newly diagnosed asymptomatic follicular lymphoma patients?
Follicular lymphoma
Watch and Wait, Worth It?
Rituximab response in follicular lymphoma: contributions from KIR 2DS1 and HLA-C
Systemic and Intra-Nodal Activation of NK Cells After Rituximab Monotherapy for Follicular Lymphoma
A rare face of follicular lymphoma: reverse variant of follicular lymphoma
Atypical burkitt's lymphoma transforming from follicular lymphoma
Follicular lymphoma of the duodenum
Follicular lymphoma of the duodenum
Follicular lymphoma and marginal zone lymphoma: how many diseases?